Heck Capital Advisors LLC Takes $1.65 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Heck Capital Advisors LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 3,260 shares of the healthcare conglomerate's stock, valued at approximately $1,649,000.

Other institutional investors have also modified their holdings of the company. Waycross Partners LLC boosted its stake in UnitedHealth Group by 2.4% during the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate's stock worth $14,060,000 after purchasing an additional 658 shares during the period. Sherbrooke Park Advisers LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter worth $515,000. Full Sail Capital LLC lifted its stake in shares of UnitedHealth Group by 2.1% in the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock worth $815,000 after acquiring an additional 33 shares during the period. Soros Fund Management LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter worth $39,413,000. Finally, Silvercrest Asset Management Group LLC lifted its stake in shares of UnitedHealth Group by 47.8% in the 4th quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate's stock worth $19,625,000 after acquiring an additional 12,550 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently commented on UNH. Mizuho reduced their target price on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research note on Friday, May 16th. Erste Group Bank downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. TD Cowen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target for the company. in a report on Monday, May 19th. Argus downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. Finally, JPMorgan Chase & Co. cut their price target on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a report on Thursday, May 15th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and a consensus target price of $441.87.

UnitedHealth Group Trading Down 0.5%

Shares of UnitedHealth Group stock traded down $1.60 during mid-day trading on Thursday, hitting $296.52. 10,880,231 shares of the stock were exchanged, compared to its average volume of 6,725,792. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The stock has a market capitalization of $268.98 billion, a price-to-earnings ratio of 19.13, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a 50-day simple moving average of $439.50 and a 200 day simple moving average of $498.65. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the prior year, the business posted $6.91 earnings per share. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Insider Buying and Selling

In other UnitedHealth Group news, CFO John F. Rex purchased 17,175 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The shares were purchased at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the transaction, the chief financial officer now directly owns 203,796 shares in the company, valued at approximately $59,329,091.52. This represents a 9.20% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Stephen J. Hemsley purchased 86,700 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the transaction, the chief executive officer now owns 679,493 shares of the company's stock, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 109,408 shares of company stock valued at $31,607,768. Insiders own 0.33% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.